Apostolia M. Tsimberidou
Hematology | Oncology
1515 Holcombe Blvd Unit 455
Houston, TX 77030
Houston, TX 77030
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 89 publications
Palbociclib in Patients With Ovarian Cancer With CDKN2A Alterations: Results From the Targeted Agent and Profiling Utilization Registry Study.
Journal: JCO precision oncology
Published: July 15, 2026
Circulating Tumor DNA Testing in Solid Tumors and Lymphoma: ASCO Guideline.
Journal: JCO oncology practice
Published: June 18, 2026
Artificial intelligence-guided analysis of the tumor microenvironment predicts response to pembrolizumab in rare tumors.
Journal: Journal for immunotherapy of cancer
Published: May 28, 2026
Extended Follow-Up of Botensilimab Plus Balstilimab in an Expanded Cohort of Microsatellite-Stable Metastatic Colorectal Cancer Without Active Liver Metastases.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 01, 2026
Clinical determinants of survival outcomes and acute toxicity after adoptive cellular therapy for solid tumors.
Journal: Frontiers in immunology
Published: April 06, 2026
A Phase 1b Study of Botensilimab and Balstilimab in Treatment-Refractory Hepatocellular Carcinoma.
Journal: Liver cancer
Published: October 07, 2025
Telemedicine as a gateway to early-phase oncology trials: lessons from 14 000 patients and future directions for global access and equity.
Journal: The oncologist
Published: September 30, 2025
Therapeutic responses in patients with advanced NSCLC enrolled in early-phase clinical trials at MD Anderson.
Journal: NPJ precision oncology
Published: September 09, 2025
Cutaneous toxicities secondary to STAT3 inhibition: A retrospective case series.
Journal: JAAD case reports
Published: July 03, 2025
Last Updated: 09/26/2026